There is no single recommended schedule for gynecologic visits after 65, because the answer depends on your health history, ongoing symptoms, and which screenings still apply to you. Many women are told they can stop cervical cancer screening at 65, and some interpret that as permission to stop seeing a gynecologist altogether. That assumption can be costly. Conditions like vulvar skin diseases, pelvic floor disorders, genitourinary symptoms from menopause, and sexually transmitted infections do not stop at 65, and several of them actually become more common or more serious with age.
Cervical Cancer Screening and the Age-65 Cutoff
The most widely cited reason for the “you’re done at 65” message is the US Preventive Services Task Force recommendation on cervical cancer screening. The USPSTF says women over 65 can stop Pap tests and HPV co-testing if they have adequate prior screening, which is defined as three consecutive negative Pap results or two consecutive negative co-test results within the prior ten years, with the most recent test done within five years.1US Preventive Services Task Force. Screening for Cervical Cancer For women who meet that bar, the risk of developing cervical cancer is very low, and continuing to screen produces more false alarms than genuine catches.
But that clean cutoff has important exceptions. Women who were treated for precancerous cervical lesions are supposed to keep screening for at least 20 years after the abnormality was managed, even if that pushes them well past 65.1US Preventive Services Task Force. Screening for Cervical Cancer And roughly 13% of women between 60 and 65 are not screened as recommended before reaching the cutoff, which means they enter their late sixties without the clean screening history needed to safely stop. Socioeconomic factors and racial disparities widen this gap further.2PubMed Central. Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data If you were never screened adequately, the standard “stop at 65” advice does not apply to you, and a conversation with your gynecologist about catching up is warranted.
Why the Stop-Screening Message Can Be Misleading
The problem is that cervical cancer screening is only one reason women see a gynecologist. When the message becomes “you don’t need a gynecologist anymore,” it collapses many distinct services into a single screening decision. About 20% of new cervical cancer cases occur in women over 65, which has prompted some researchers to argue that the age cutoff deserves re-evaluation as the population ages and sexual behaviors change.3Europe PMC. It’s time to re-evaluate cervical Cancer screening after age 65 Older women also develop cervical cancer even after meeting the screening cessation criteria, which means the cutoff is a population-level guideline, not a personal guarantee.2PubMed Central. Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data
Beyond cervical screening, there is an ongoing disagreement among medical societies about whether asymptomatic women benefit from routine pelvic exams at all. The American College of Physicians recommends against pelvic exams in asymptomatic, nonpregnant women, citing evidence of harm from false-positive results and unnecessary procedures. The American College of Obstetricians and Gynecologists, by contrast, recommends annual pelvic exams for women starting at 21, based on expert opinion.4PubMed Central. Effect of professional society recommendations on women’s desire for a routine pelvic examination This disagreement means your answer may depend on which professional society your provider follows. If you have no symptoms and no ongoing risk factors, a yearly pelvic exam may not be necessary. But “no symptoms” is doing a lot of work in that sentence, because many gynecologic conditions in older women progress silently for years before symptoms become obvious.
Vulvar Conditions That Require Long-Term Monitoring
One of the strongest arguments for continued gynecologic care after 65 is vulvar health. Lichen sclerosus, a chronic inflammatory skin condition of the vulva, is most commonly diagnosed around age 60 and carries a real risk of progressing to vulvar cancer over time. In a study of nearly a thousand women with the condition, the cumulative probability of developing a vulvar neoplasm rose from about 1% at two years to nearly 37% at 25 years. Older women, particularly those 70 and above, had significantly shorter progression-free survival compared to younger patients.5Journal of Lower Genital Tract Disease. Vulvar Lichen Sclerosus and Neoplastic Transformation: A Retrospective Study of 976 Cases That risk profile makes long-term follow-up essential, not optional.
Making matters worse, vulvar conditions are frequently diagnosed late. One review found an average delay of more than two years between symptom onset and diagnosis of vulvar pathology, highlighting how easily these problems get overlooked when women stop seeing a gynecologist or when providers do not routinely examine the vulva.6International Journal of Gynecological Cancer. How Often Should You See a Gynecologist After 65? The takeaway is clear: if you have been diagnosed with lichen sclerosus or any chronic vulvar condition, you need ongoing monitoring indefinitely, and that means regular visits to someone examining the area, whether a gynecologist or a dermatologist with vulvar expertise.
Genitourinary Syndrome of Menopause
The hormonal changes of menopause do not level off at 65. They keep progressing. Genitourinary syndrome of menopause is a broad term for the vaginal dryness, irritation, urinary symptoms, and painful intercourse that result from the loss of estrogen after menopause. Unlike hot flashes, which tend to diminish over time, genitourinary symptoms typically worsen without treatment.7PubMed Central. Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause This is a progressive condition: the vaginal tissue thins, the urinary tract becomes more vulnerable to infection, and daily comfort can erode steadily.
First-line treatments start with over-the-counter lubricants and vaginal moisturizers, but when those are not enough, low-dose vaginal estrogen is widely considered the most effective option.8PubMed Central. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data Newer approaches, including selective estrogen receptor modulators and energy-based devices like vaginal lasers, are being studied but are not yet established enough for routine clinical use.9PubMed Central. Modern management of genitourinary syndrome of menopause The point for scheduling purposes is that managing these symptoms requires a provider who can prescribe and adjust vaginal hormone therapy, evaluate your response, and rule out other causes when symptoms change. That is a reason for periodic gynecologic visits even if no cancer screening is on the agenda.
Postmenopausal Bleeding Is Always Worth Investigating
Any vaginal bleeding after menopause should prompt a visit, regardless of how long it has been since your last period. Postmenopausal bleeding is the most common symptom of endometrial cancer, present in about 90% of cases across all tumor stages. The reassuring counterpoint is that most women who experience postmenopausal bleeding will not have cancer. Across a large pooled analysis, the risk of endometrial cancer among women with postmenopausal bleeding was about 9%, varying somewhat by hormone therapy use and geographic region.10PubMed Central. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis Still, roughly one in ten is not a number to ignore. The bleeding is far more likely to be caused by something benign like atrophy or polyps, but the only way to know is through evaluation, typically an ultrasound or endometrial biopsy.
This is an example of symptom-driven care rather than routine screening. You do not need regularly scheduled endometrial biopsies if you have no symptoms. But you do need to know that postmenopausal bleeding is not normal and warrants prompt assessment. Women who have stopped seeing a gynecologist may be more likely to dismiss bleeding as unimportant or feel unsure where to go for help.
Ovarian Cancer and the Limits of Screening
Unlike cervical and breast cancers, there is no effective screening test for ovarian cancer in the general population. The USPSTF recommends against ovarian cancer screening in asymptomatic women, noting that the tests available, including CA-125 blood tests and transvaginal ultrasound, cannot reliably detect ovarian cancer early enough to save lives and can lead to harm, including unnecessary surgical removal of healthy ovaries.11JAMA. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement Studies in asymptomatic postmenopausal women confirm that screening produces low positive predictive values and increases rates of surgery and patient anxiety without a clear survival benefit.12Journal of Obstetrics and Gynaecology Canada. Assessment of Ovarian Cancer Screening in Asymptomatic Postmenopausal Women
This means that routine visits to a gynecologist will not catch ovarian cancer through a screening protocol. What a gynecologist can do is evaluate symptoms, particularly persistent bloating, pelvic pain, difficulty eating, or urinary urgency, that might otherwise be attributed to aging or digestive issues. The absence of a screening test makes symptom awareness and clinical vigilance more important, not less.
Breast Screening After 65
Mammography is typically managed by your primary care provider or a breast-health specialist rather than a gynecologist, but many women receive breast screening reminders through their gynecologist’s office, and losing that connection after 65 can mean mammograms fall off the radar. Unlike cervical cancer screening, there is no firm consensus on an upper age limit for mammography in the United States. Major medical societies have issued varying recommendations, and population-wide screening has largely continued without a clear stopping age.13PubMed Central. Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms
There is growing recognition, however, that the benefits of mammography decrease and the harms increase as women age. One study examining screening outcomes found that breast tumors grow more slowly in older women, which increases overdiagnosis: detecting cancers that would never have caused symptoms or death during a woman’s remaining lifetime. That research concluded that 75 is a reasonable upper age limit for population-based mammography programs.14PubMed. Seventy-five years is an appropriate upper age limit for population-based mammography screening In practice, the decision to continue screening is best made individually, weighing your overall health, life expectancy, and personal preferences. A gynecologist or primary care provider familiar with your history can help with that conversation.
Sexual Health and STIs in Older Adults
Sexual health does not expire at 65, but the conversation around it often does. Sexually transmitted infections among older adults are an underrecognized and growing public health concern, driven by factors including low condom use, limited sexual health education, physiological changes that increase vulnerability to infection, and a widespread reluctance among both patients and providers to discuss sex in older age.15PubMed Central. Sexually transmitted infections in the elderly: A growing concern in geriatric care A systematic review examining chlamydia, gonorrhea, and syphilis in older adults found prevalence ranges that, while variable, reached as high as 14-18% in some study populations.16PubMed. The burden of chlamydia, gonorrhea, and syphilis in older adults in the United States: A systematic review
Older adults also tend to know less about STIs than younger people. In a study measuring STI knowledge, older participants answered correctly on fewer than half of the questions asked.17PubMed Central. Sexually Transmitted Infection Knowledge among Older Adults: Psychometrics and Test–Retest Reliability The thinning of vaginal tissue after menopause can make the mucosa more susceptible to infection, and the loss of the acidic vaginal environment that helps protect against pathogens compounds the problem. If you are sexually active after 65, particularly with new partners, STI screening and frank conversations about sexual health belong in your healthcare routine. A gynecologist is well positioned to provide both, but only if you are still making appointments.
Pelvic Floor Disorders
Urinary incontinence, pelvic organ prolapse, and fecal incontinence become increasingly common with age and represent one of the most frequent reasons older women seek gynecologic or urogynecologic care.18PubMed Central. Prolapse and Incontinence Surgery in the Older Woman These conditions range from mildly annoying to severely disabling, and they often go unaddressed because women assume incontinence or prolapse is just a normal part of aging that they should tolerate. It is common, but “common” and “untreatable” are different things. Pelvic floor physical therapy, pessary devices, medications, and surgical options are all available, and the evaluation starts with a gynecologist or urogynecologist who can examine the pelvic anatomy and determine the severity.
Many women with pelvic floor problems also have overlapping genitourinary symptoms from menopause, and the two conditions can worsen each other. Treating vaginal atrophy with local estrogen, for instance, can sometimes improve mild urinary symptoms simultaneously. This interconnectedness is another reason why continued access to a gynecologist matters. A primary care doctor can address some of these issues, but the physical examination of pelvic support structures is a core gynecologic skill.
Hormone Therapy After 65
The question of whether to continue, start, or stop menopausal hormone therapy after 65 is one that benefits from gynecologic guidance. A large study examining the effects of hormone therapy beyond age 65 found that estrogen-only therapy after 65 was associated with meaningful reductions in mortality, breast cancer, lung cancer, heart attack, and dementia compared with stopping or never using it. The picture was more complicated for combination therapy with estrogen and progestin, which was associated with a 10-19% increase in breast cancer risk but also with reductions in endometrial cancer, ovarian cancer, and heart failure. The breast cancer risk could be reduced with lower doses or transdermal delivery methods.19PubMed Central. Use of menopausal hormone therapy beyond age 65 years and its effects on women’s health outcomes by types, routes, and doses
These findings suggest that the old blanket advice to stop hormone therapy at a certain age is too simple. For women who had hysterectomies and can use estrogen alone, continuing past 65 may have genuine protective benefits. For women on combination therapy, the risk-benefit calculation depends on the specific formulation, dose, and route of delivery. Either way, this is not a decision to make by yourself or by Googling. It requires regular clinical follow-up with a provider who understands the nuances of hormone prescribing in older women.
Life Expectancy and the Screening Conversation
Many cancer screening guidelines now suggest factoring in life expectancy when deciding whether to continue screening in older adults. The logic is straightforward: screening finds slow-growing cancers, and if a woman is unlikely to live long enough for a slow-growing cancer to cause harm, screening may create more anxiety and unnecessary procedures than it prevents. But translating this principle into practice is remarkably difficult. Clinicians report uncertainty about how to estimate life expectancy for individual patients, and older adults themselves are generally not enthusiastic about having their remaining years factored into healthcare decisions.20PubMed Central. Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison
In practice, this means that a healthy 70-year-old with a life expectancy of 15 or more years may benefit from continued screening in ways that an 80-year-old with multiple chronic illnesses would not. The decision should be individualized, but it requires a provider who knows your full medical picture. Whether that provider is a gynecologist, a primary care physician, or both depends on your healthcare setup. The key point is that “after 65” is not a single category. A 66-year-old and an 86-year-old have very different risk profiles, and their gynecologic care should reflect that.
Who Should Be Seeing a Gynecologist and How Often
There is no universal schedule that works for every woman over 65. But based on the conditions and screenings outlined above, here is a rough guide to help you think about it:
- Annually or more: Women with chronic vulvar conditions like lichen sclerosus, those on hormone therapy requiring monitoring, or those with active pelvic floor symptoms being managed.
- Every one to three years: Women with genitourinary symptoms of menopause being treated with vaginal estrogen, sexually active women who may benefit from periodic STI screening, and those continuing mammography through their gynecologist’s office.
- Symptom-driven only: Women with no ongoing gynecologic conditions, adequate prior cervical screening, and no current symptoms. Even then, any new vaginal bleeding, vulvar changes, pelvic pain, or urinary problems should prompt a visit without delay.
The most dangerous choice is to stop all gynecologic care entirely and assume that nothing can go wrong after 65. At the same time, healthy women who have been thoroughly screened and have no symptoms do not need to be in a gynecologist’s office every year out of habit. The right frequency is a conversation, not a rule, and it should be revisited as your health changes over time. If your primary care provider is comfortable managing these issues and performing the relevant examinations, they can fill much of this role. But if symptoms arise that are outside their expertise, a gynecologist remains an important part of the team.
Bone Health as a Gynecologic Concern
Osteoporosis sits at the intersection of gynecology and general medicine because estrogen loss is the primary driver of bone density decline in postmenopausal women. Screening is typically done with a DEXA scan and can be initiated based on risk factors like age, weight, ethnicity, and whether menopause occurred early. Women identified as high risk or already diagnosed with osteoporosis need treatment, which can range from bisphosphonates to hormone therapy, and ongoing monitoring.21PubMed Central. Menopausal osteoporosis: screening, prevention and treatment Some gynecologists manage osteoporosis directly, while others coordinate with endocrinologists or primary care providers. Either way, bone health is another thread that ties back to the hormonal changes your gynecologist understands best, and losing that expertise from your care team can leave a gap that nobody else fills.